Three independent discounted-cash-flow-style models value Hims & Hers Health, Inc. every trading day. 0 of 3 currently price HIMS above its market price.
| Free Cash Flow model | $-40.92 |
| Excess Profit model | $-23.77 |
| Residual Earnings model | $0.13 |
| Dividend Discount model | — |
| Piotroski F-Score | 5 / 9 |
| Return on invested capital | +4.8% |
| Net debt / EBITDA | 9.3× |
| Gross margin | +73.8% |
| Revenue CAGR | +64.5% |
| Cash conversion | 2.3× |
| Dividend yield | — |
| Buyback yield | -4.2% |
These are StockKitty's default assumptions. In the app, the models recompute live as you adjust growth, discount rates, and margins — and the AI explains the bull case, bear case, and quality picture.
Open HIMS in StockKitty